lead - search results

Mechanical characterisation of high-performance materials has been a long-standing area of expertise at Swansea University. A succession of academics has promoted an intimate relationship with the power generation industry, in particular, working on alloys aligned to gas turbine technologies. A world-renowned research group focussing on high-temperature creep, fatigue and...

John Laughlin, Aerospace Programme Lead at Innovate UK answers AG’s questions regarding investment in the aerospace industry and how Innovate UK play an integral role in this UK businesses are well placed to take advantage of growing global demand for faster, quieter and greener aircraft. As the biggest aerospace industry...

Open Access Government looks at how health research can play a pivotal role in preventing major diseases throughout the country  Over the decades we have changed the way we live, which can have a major impact on our health. For example, new technologies we use and the environment can all...

Recent participatory research from the Canadian North adds nuance to global literature on gender, climate change, and mental wellbeing Climate change has been identified as the greatest threat to human health this century. Global Climate Change & Health Impacts It is anticipated that the impacts will have wide-ranging consequences globally, including increased risk,...

Dr João Breda and Jo Jewell from the WHO Regional Office for Europe highlight the latest projections in regards to obesity throughout Europe and how WHO works with countries to reduce the burden Of the 6 WHO regions, the European Region is the most severely affected by non-communicable diseases (NCDs):...

From informal payments to industry kickbacks… In October 2013 the European Commission has published a “Study on corruption in healthcare” (HOME/2011/ISEC/PR/047-A2). The study was developed by ECORYS , a Dutch consultancy and research company, in collaboration with EHFCN, the European Healthcare Fraud and Corruption Network. Aside from being the first ever on...

Joel Alleyne from the Global Health Care Anti-fraud Network (GHCAN) outlines how the organisation helps with the fight against healthcare fraud  At a conference in Edinburgh in October 2009, the European (including the UK NHS), American, and Canadian health care anti-fraud associations signed a Memorandum of Understanding to combine their efforts...

Reform of the UK’s relationship with the EU is set to enter a crucial phase as the Prime Minister begins discussions with European Council President Donald Tusk… David Cameron is set to enter a crucial day of talks with European Council President Donald Tusk. The Prime Minister is seeking to...

Christa Sedlatschek, Director at the European Agency for Safety and Health at Work outlines how musculoskeletal disorders affect workplaces across Europe Across Europe, musculoskeletal disorders (MSDs) are one of the most common occupational safety and health (OSH) risks in the workplace. They are found across many sectors, including agriculture, construction,...

Ilias Iakovidis and Bruno Alves from DG CONNECT at the European Commission explain how digital transformation can turn demographic change into an opportunity for Europe The challenges resulting from demographic change are well documented and have been moved over the years from technical to strategic and recently to political debate...

Ductal carcinoma in situ (DCIS) is an early form of breast cancer that can be treated with surgery. Surgery can involve removal of the entire breast or partial removal of the tumour and the breast tissue surrounding it. In the case of partial removal, the challenge is knowing how...

Hollie Chandler, Senior Policy Advisor at Cancer Research UK highlights the work being done to improve treatment for childhood cancers In the UK around 3,800 children, teenagers and young adults are diagnosed with cancer each year, that’s 73 every week. Thanks to new treatments, survival rates are improving. More than 80% of...

Debbie Laycock, Head of Policy at the Terrence Higgins Trust sheds light on the future of HIV among budget cuts and already stretched key services  Many readers will remember HIV and AIDS in the 1980s – the gravestone adverts and the public health campaign that we recently heard Margaret Thatcher...

Nucleated blood platelets are produced by their bone marrow resident precursors, the megakaryocytes, in a unique process in mammalian physiology. Terminally differentiated, polyploid megakaryocytes are the largest cells in the bone marrow evolving from hematopoietic stem cells. Megakaryocytes are localised in close proximity to sinusoidal blood vessels and convert...

Infectious diseases are a major cause for animal suffering and production losses in livestock and at the same time, often being zoonotic, represent a serious hazard for food safety. Combating infectious diseases of livestock is, therefore, a top priority on the veterinary and public health agenda. Mass use of...

The European Confederation of Pharmaceutical Entrepreneurs (EUCOPE) is Europe’s principal trade body for small to medium-sized innovative companies working in the field of pharmaceuticals. Via its company members and national member associations such as the British Ethical Medicines Industry Group (EMIG), the German Pharmaceutical Industry Association (BPI), BioDeutschland, the...

The EU and its Member States have faced unprecedented challenges in recent years. Citizens rightly demand more jobs and long term sustainable growth. They expect a more effective response to migration. They want to see all governments maintain stability in and outside EU borders. These issues directly affect Europe’s...

Ramón Cacabelos, of EuroEspes Biomedical Research Center discusses the strides being made in drug development for Alzheimer's disease... Alzheimer’s disease (AD) is a major problem of health and a national priority in developed countries. Despite enormous efforts by governments, the scientific community and the pharmaceutical industry over the past 50 years,...

The background of building renovation in both Nordic and European projects, where actual energy use is quite often 30-40% higher in practice compared to what was expected from calculations, and where innovative solutions are seldom used, is very much connected to the way the building industry is organised. Here,...

The background of building renovation in both Nordic and European projects, where actual energy use is quite often 30-40% higher in practice compared to what was expected from calculations, and where innovative solutions are seldom used, is very much connected to the way the building industry is organised. Here,...